It was found that CCL15 produced by follicular thyroid cancer cells is responsible for the recruitment of TAMs, which could be inhibited by treatment with a CCL15 blocking antibody [60]. This evidence concerns the gene CCL15 and thyroid gland follicular carcinoma.